Wood Larry L

SEC source: 0001628280-26-054970 · wk-form4_1786356427.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · The Larry Wood Trust

Disclosed balance after: 23,900

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $20.67 to $21.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

SEC source: 0001628280-26-016156 · wk-form4_1773092704.xml · derivative · entry 2

Wood Larry L · CIK 0001440660 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,653

Underlying: Common Stock · 103,653 shares

Expires 2036-03-04

F2 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.

SEC source: 0001628280-26-016156 · wk-form4_1773092704.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 313,378

F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2027, with onesixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date.

SEC source: 0001440660-25-000004 · wk-form4_1757021993.xml · derivative · entry 2

Wood Larry L · CIK 0001440660 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 319,618

Underlying: Common Stock · 319,618 shares

Expires 2036-09-01

F3 · derivative.exercise_date: The Stock Option was granted on September 2, 2025 and one-quarter of the shares subject to the Stock Option will vest on September 2, 2026, and the remainder shall vest monthly thereafter at the rate of 1/48th of the original number of shares subject to the Stock Option, subject to the Reporting Person continuing as a service provider through such date.

SEC source: 0001440660-25-000004 · wk-form4_1757021993.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 185,595

F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on September 2, 2026, with one-twelfth of the remaining RSUs shall vest on each quarter thereafter, subject to the Reporting Person continuing as a service provider through such date.

F2 · balance_after: The ending balance was adjusted to reflect the forfeiture (for no consideration) of 2,765 unvested RSUs previously granted to the Reporting Person in April 2024 and June 2025 under the issuer's non-employee director compensation program.

SEC source: 0001225208-25-007321 · doc4.xml · derivative · entry 4

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,800

Underlying: Common Stock · 8,950 shares

Expires 2026-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-25-007321 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 206,900.3913

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025.

F2 · price: This transaction was executed in multiple trades at prices ranging from $77.68 to $78.43. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001225208-25-007321 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 215,850.3913

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025.

SEC source: 0001225208-25-005981 · doc4.xml · derivative · entry 4

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 44,750

Underlying: Common Stock · 8,950 shares

Expires 2026-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-25-005981 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 206,900.3913

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025.

F2 · price: This transaction was executed in multiple trades at prices ranging from $74.8901 to $75.4400. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001225208-25-005981 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 215,850.3913

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025.

SEC source: 0001628280-25-030987 · wk-form4_1749759946.xml · derivative · entry 2

Wood Larry L · CIK 0001440660 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,771

Underlying: Common Stock · 2,771 shares

Expires 2035-06-09

F2 · derivative.exercise_date: The Stock option was granted on June 10, 2025 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001628280-25-030987 · wk-form4_1749759946.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,968

F1 · kind: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001225208-25-004995 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 206,900.3913

SEC source: 0001225208-25-004940 · doc4.xml · derivative · entry 5

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,050

Underlying: Common Stock · 11,050 shares

Expires not disclosed

F3 · derivative.exercise_price: Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards.

F3 · derivative.expiration_date: Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards.

SEC source: 0001225208-25-004940 · doc4.xml · derivative · entry 4

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,000

Underlying: Common Stock · 62,000 shares

Expires 2032-05-07

F2 · derivative.exercise_date: These options were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments.

SEC source: 0001225208-25-004940 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 207,888.3913

F1 · shares: These restricted stock units were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.

SEC source: 0001225208-25-004940 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 196,838.3913

SEC source: 0001225208-25-004768 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 197,657.3913

SEC source: 0001225208-25-004768 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 198,067.3913

SEC source: 0001225208-25-001907 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 198,192.739

SEC source: 0001225208-24-009655 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 198,525.739

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 1, 2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $65.54 to $66.27. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001628280-24-027045 · wk-form4_1717705635.xml · derivative · entry 2

Wood Larry L · CIK 0001440660 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,526

Underlying: Common Stock · 2,526 shares

Expires 2034-06-03

F2 · derivative.exercise_date: The Stock Option was granted on June 4, 2024 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001628280-24-027045 · wk-form4_1717705635.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,430

F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001225208-24-005984 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 223,525.739

SEC source: 0001225208-24-005887 · doc4.xml · derivative · entry 5

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,725

Underlying: Common Stock · 8,725 shares

Expires not disclosed

F3 · derivative.exercise_price: Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards.

F3 · derivative.expiration_date: Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2027. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards.

SEC source: 0001225208-24-005887 · doc4.xml · derivative · entry 4

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,700

Underlying: Common Stock · 51,700 shares

Expires 2031-05-06

F2 · derivative.exercise_date: These options were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments.

SEC source: 0001225208-24-005887 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 224,510.739

SEC source: 0001225208-24-005887 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,205.739

F1 · shares: These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.

SEC source: 0001225208-24-005703 · doc4.xml · derivative · entry 5

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,675 shares

Expires 2028-05-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4.

SEC source: 0001225208-24-005703 · doc4.xml · nonDerivative · entry 3

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 216,480.739

SEC source: 0001225208-24-005703 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 220,021.739

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4.

F1 · price: On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4.

SEC source: 0001225208-24-005703 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 213,346.739

SEC source: 0001628280-24-017007 · wk-form4_1713568017.xml · derivative · entry 2

Wood Larry L · CIK 0001440660 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,284

Underlying: Common Stock · 5,284 shares

Expires 2034-04-17

F2 · derivative.exercise_date: This Stock Option was granted on April 18, 2024, and one-third of the shares subject to the Stock Option shall vest on April 18, 2025, with one-third of the remaining shares subject to the Stock Option vesting annually on each of the second and third anniversary thereof, subject to the Reporting Person continuing as a service provider through such date.

SEC source: 0001628280-24-017007 · wk-form4_1713568017.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,054

F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-third of the RSUs shall vest on April 18, 2025, with one-third of the remaining RSUs vesting annually on each of the second and third anniversary thereof, subject to the Reporting Person continuing as a service provider through such date.

SEC source: 0001225208-24-002344 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 213,476.7137

SEC source: 0001225208-23-011073 · doc4.xml · derivative · entry 4

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,658 shares

Expires 2025-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-23-011073 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 213,793.7137

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023.

SEC source: 0001225208-23-011073 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 222,451.7137

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023.

SEC source: 0001225208-23-010211 · doc4.xml · derivative · entry 6

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,658

Underlying: Common Stock · 8,660 shares

Expires 2025-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-23-010211 · doc4.xml · nonDerivative · entry 4

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 213,793.7137

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $65.21 to $66.16. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001225208-23-010211 · doc4.xml · nonDerivative · entry 3

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 219,195.7137

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $64.20 to $65.13. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001225208-23-010211 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 222,353.7137

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023.

SEC source: 0001225208-23-010211 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 222,453.7137

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023.

SEC source: 0001225208-23-009479 · doc4.xml · derivative · entry 5

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,318

Underlying: Common Stock · 8,660 shares

Expires 2025-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-23-009479 · doc4.xml · nonDerivative · entry 3

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 213,793.7137

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $70.05 to $70.48. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001225208-23-009479 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 218,943.7137

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $69.05 to $70.04. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001225208-23-009479 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 222,453.7137

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023.

SEC source: 0001225208-23-008936 · doc4.xml · derivative · entry 4

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 25,978

Underlying: Common Stock · 8,660 shares

Expires 2025-05-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001225208-23-008936 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · Global President TAVR & Surg

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 213,793.7137

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 17, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $73.23 to $73.81. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.